MB11111 Posted - 11 hours ago

$SNTI https://investors.sentibio.com/static-files/d663652e-c38b-4416-9376-5967679806c8

Kovyarmy Posted - 5 days ago

$SNTI gobbled up that early morning dip

BioTechChap Posted - 5 days ago

$SNTI Despite the delay, the team is executing. Important FIH study milestone.

NEWBIGTECH Posted - 5 days ago

$SNTI

MB11111 Posted - 5 days ago

$SNTI https://www.linkedin.com/posts/senti-biosciences_celltherapy-aml-carnk-activity-7195759226948890624-TSll?utm_source=share&utm_medium=member_ios

Stock_Titan Posted - 5 days ago

$SNTI Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia https://www.stocktitan.net/news/SNTI/senti-bio-announces-first-patient-dosed-in-phase-1-clinical-trial-of-3o2f2ys1w5lf.html

MB11111 Posted - 1 week ago

$SNTI time to get the clinical tests going!

Stock_Titan Posted - 1 week ago

$SNTI Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate Highlights https://www.stocktitan.net/news/SNTI/senti-bio-announces-first-quarter-2024-results-and-reviews-recent-u5vc30rb5jfe.html

NEWBIGTECH Posted - 1 week ago

$SNTI SNTI SNTI SNTI Enough Cheerleading. Where is everyone. 1383 Watchers. Get the word out and lets move the stock up.

NEWBIGTECH Posted - 1 week ago

$SNTI KEB MO does it best. .. SENTI-202, a potential first-in-class, off-the-shelf logic-gated CAR-NK investigational cell therapy for the treatment of AML. Senti Bio is on track to initiate patient dosing in the second quarter of 2024, with initial efficacy data anticipated by year-end 2024 and initial durability data following in 2025.

stocksching Posted - 1 week ago

$CADL $SNTI Bullish

stocksching Posted - 1 week ago

$CADL . $SNTI

stocksching Posted - 1 week ago

$BTC.X $SNTI

stocksching Posted - 1 week ago

$GME $SNTI .

stocksching Posted - 1 week ago

$AMC $SNTI

MB11111 Posted - 2 weeks ago

$SNTI https://www.linkedin.com/posts/senti-biosciences_asgct2024-celltherapy-genecircuits-activity-7192191380360691712-Rqk9?utm_source=share&utm_medium=member_ios

never2much Posted - 2 weeks ago

$SNTI OUT! GL

Ned_Nosurname Posted - 04/30/24

$SNTI Oral presentation https://annualmeeting.asgct.org/abstracts/abstract-details?abstractId=60213

never2much Posted - 04/30/24

$SNTI GREAT! This is the future of cancer cures I do believe. Natural KILLER cells that are biologically engineered to DESTROY cancer cells and only cancer cells. Took up a small position to hold.

RETAlerts Posted - 04/30/24

$SNTI at 0.416 has shown some initial momentum, and is 5% up since landing on our scanner, let's see if any overhead resistance levels get broken with conviction. (15 minute delay)

MB11111 Posted - 04/30/24

$SNTI pre market activity?!

Stock_Titan Posted - 04/30/24

$SNTI Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML) https://www.stocktitan.net/news/SNTI/senti-bio-announces-publication-of-senti-202-preclinical-data-idz4sneml32v.html

BioTechChap Posted - 04/25/24

@NEWBIGTECH This ticker clearly has lost its sex appeal. Difficult to grasp how deeply undervalued the gating IP is here. A major fund (Bakers Bros, RA Capital etc.) would need to take a stake in the company, lift market cap and then start exploring premiums for acquisition. That would be the ideal playbook, but I guess I’m wishful thinking like I always do! My biggest concern is that the CEO, as talented he may be, is not 100% dedicated to the company as he has multiple startup entities running in parallel. $SNTI

NEWBIGTECH Posted - 04/25/24

$SNTI clearing IND for SENTI-202, securing strategic collaborations, and reporting financial results. The company focuses on advancing SENTI-202 in the U.S. and SENTI-301A in China, with promising pipeline programs. Financially, Senti Bio holds $35.9 million in cash and expects operations funded into Q1 2025. Buy out candidate? Who? $MRK $JNJ $PFE

MB11111 Posted - 1 month ago

$SNTI no wonder this stock is dead…check the presentation…! senti investor relations need to step up their game! https://www.sentibio.com/application/files/8517/1292/6805/2024_AACR_Kaveri_et_al_SENTI-202_Poster_FINAL_1.pdf

Kayzon Posted - 1 month ago

$SNTI https://bgandg.com/snti/

NEWBIGTECH Posted - 1 month ago

$SNTI a potential first-in-class off-the-shelf CAR-NK cell therapy, SENTI-202, is being developed to selectively target and eliminate CD33 and/or FLT3 expressing hematologic malignancies, like AML and myelodysplastic syndrome (MDS), while not affecting the healthy bone marrow cells. Following the FDA’s clearance of the IND, Senti Bio plans to initiate a phase I study on SENTI-202 at various sites in the United States and Australia. The first patient in the study is expected to be treated in the second quarter of 2024.

NEWBIGTECH Posted - 1 month ago

We neeD $SNTI volume. We need watchers and news.

MB11111 Posted - 1 month ago

$SNTI https://www.linkedin.com/posts/senti-biosciences_aml-aacr24-carnk-activity-7182010109697359874-6v3X?utm_source=share&utm_medium=member_ios

RollingDollar Posted - 1 month ago

$SNTI .